Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to PPP1R9B" (ENSG00000297935, also known as LOC124904025) refers to an uncharacterized transcript identified on the opposite (antisense) strand of the PPP1R9B gene locus. As an antisense RNA, it does not encode a known protein product and lacks established biological function or disease association. There is no evidence indicating that this locus is a validated therapeutic target, nor that it participates in canonical signaling, receptor, or enzymatic pathways. Most available data simply annotate it as a predicted or computationally identified transcript, not a protein-coding gene or functional target. In contrast, PPP1R9B itself (encoding spinophilin/neurabin-2) is a well-characterized scaffold protein involved in synaptic signaling and cytoskeletal regulation, but "novel transcript, antisense to PPP1R9B" should not be confused with PPP1R9B itself[1][3][5][7].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to PPP1R9B (ENSG00000297935 (also annotated as LOC124904025)).